Author:
Patin Franck,Corcia Philippe,Vourc’h Patrick,Nadal-Desbarats Lydie,Baranek Thomas,Goossens Jean-François,Marouillat Sylviane,Dessein Anne-Frédérique,Descat Amandine,Madji Hounoum Blandine,Bruno Clément,Leman Samuel,Andres Christian R,Blasco Hélène
Funder
ARSLA
Fondation Brou de Laurières
Publisher
Springer Science and Business Media LLC
Subject
Neuroscience (miscellaneous),Cellular and Molecular Neuroscience,Neurology
Reference69 articles.
1. Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. (2009) Prognostic factors in ALS: a critical review. Amyotroph. Lateral Scler. Off. Publ. World fed. Neurol. Res. Group mot. Neuron Dis. 10:310–323
2. Bensimon G, Lacomblez L, Meininger V (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330:585–591
3. Miller RG, Mitchell JD, Moore DH (2012) Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 3:CD001447
4. Dupuis L, Pradat P-F, Ludolph AC, Loeffler J-P (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10:75–82
5. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrère B, et al. (2001) Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 74:328–334
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献